Literature DB >> 29930853

Incidence and characteristics of biphasic and protracted anaphylaxis: evaluation of 114 inpatients.

Seiro Oya1, Tomoki Nakamori1, Hirohisa Kinoshita1.   

Abstract

AIM: Anaphylaxis is a systemic allergic reaction that potentially causes death. Most anaphylactic reactions are uniphasic, but some cases may be biphasic or protracted. However, these clinical epidemiology concepts are unfamiliar in Japan. Therefore, we have investigated the incidences and characteristics of patients with biphasic and protracted anaphylaxis.
METHODS: We retrospectively evaluated patients with anaphylaxis in a single emergency medical center located in Yokohama, Japan from April 2009 to March 2012. We analyzed the incidences and characteristics of patients with biphasic and protracted anaphylaxis who needed to be admitted.
RESULTS: A total of 253 patients were diagnosed with anaphylaxis and 114 patients needed to be admitted. Of the 114 patients, 103 (90.4%) were uniphasic, 7 (6.1%) were biphasic and 4 (3.5%) were protracted anaphylaxis. The most common antigens were foods and drugs. The median onset of a biphasic reaction was 8 h and dermatologic symptoms were mostly observed. Regarding severity, mild symptoms were seen in four cases, similar symptoms to the initial reaction were seen in two cases, and only one case was severe. The duration of protracted anaphylaxis varied from 2 to 8 days.
CONCLUSION: The incidence of biphasic and protracted anaphylaxis in inpatients was 6.1% and 3.5%, respectively. The median onset of biphasic reaction was 8 h, and most symptoms were mild or similar to the initial reaction. We suggest that patients with anaphylaxis need an 8-h and ideally a 24-h observation period in order to monitor possible biphasic reactions. The duration of protracted anaphylaxis was up to 8 days.

Entities:  

Keywords:  Anaphylaxis; biphasic reaction; emergency department; observation period; protracted reaction

Year:  2014        PMID: 29930853      PMCID: PMC5997245          DOI: 10.1002/ams2.48

Source DB:  PubMed          Journal:  Acute Med Surg        ISSN: 2052-8817


  17 in total

Review 1.  Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations.

Authors:  John W Tole; Phil Lieberman
Journal:  Immunol Allergy Clin North Am       Date:  2007-05       Impact factor: 3.479

2.  Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study.

Authors:  Ronit Confino-Cohen; Arnon Goldberg
Journal:  Ann Allergy Asthma Immunol       Date:  2010-01       Impact factor: 6.347

3.  Biphasic systemic anaphylactic reaction: three illustrative cases.

Authors:  V T Popa; S A Lerner
Journal:  Ann Allergy       Date:  1984-08

Review 4.  Anaphylaxis.

Authors:  F Estelle R Simons
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

Review 5.  Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization.

Authors:  S F Kemp; R F Lockey; F E R Simons
Journal:  Allergy       Date:  2008-08       Impact factor: 13.146

6.  National study of US emergency department visits for acute allergic reactions, 1993 to 2004.

Authors:  Theodore J Gaeta; Sunday Clark; Andrea J Pelletier; Carlos A Camargo
Journal:  Ann Allergy Asthma Immunol       Date:  2007-04       Impact factor: 6.347

7.  Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.

Authors:  Hugh A Sampson; Anne Muñoz-Furlong; Ronna L Campbell; N Franklin Adkinson; S Allan Bock; Amy Branum; Simon G A Brown; Carlos A Camargo; Rita Cydulka; Stephen J Galli; Jane Gidudu; Rebecca S Gruchalla; Allen D Harlor; David L Hepner; Lawrence M Lewis; Phillip L Lieberman; Dean D Metcalfe; Robert O'Connor; Antonella Muraro; Amanda Rudman; Cara Schmitt; Debra Scherrer; F Estelle R Simons; Stephen Thomas; Joseph P Wood; Wyatt W Decker
Journal:  J Allergy Clin Immunol       Date:  2006-02       Impact factor: 10.793

8.  Fatal and near-fatal anaphylactic reactions to food in children and adolescents.

Authors:  H A Sampson; L Mendelson; J P Rosen
Journal:  N Engl J Med       Date:  1992-08-06       Impact factor: 91.245

9.  Incidence and characteristics of biphasic reactions after allergen immunotherapy.

Authors:  Stephen E Scranton; Erika G Gonzalez; Kirk H Waibel
Journal:  J Allergy Clin Immunol       Date:  2008-12-06       Impact factor: 10.793

Review 10.  Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma.

Authors:  Susan L Limb; Peter R Starke; Charles E Lee; Badrul A Chowdhury
Journal:  J Allergy Clin Immunol       Date:  2007-10-22       Impact factor: 10.793

View more
  4 in total

1.  Association between biphasic reactions and the systems of symptoms and treatment in patients with anaphylaxis hospitalized from the emergency department.

Authors:  Tomohisa Nomura; Hajime Sekii; Manabu Sugita; Shinji Nakahara
Journal:  Acute Med Surg       Date:  2020-11-12

2.  Simulation of Health and Economic Benefits of Extended Observation of Resolved Anaphylaxis.

Authors:  Marcus Shaker; Dana Wallace; David B K Golden; John Oppenheimer; Matthew Greenhawt
Journal:  JAMA Netw Open       Date:  2019-10-02

3.  Anaphylaxis and other allergic reactions to food: a global challenge.

Authors:  Antonio Jose Reyes; Amanda Sheena Hosein; Kanterpersad Ramcharan; Sean Perot
Journal:  BMJ Case Rep       Date:  2020-05-14

4.  Incidence and timing of biphasic anaphylactic reactions: a retrospective cohort study.

Authors:  Motohiro Ichikawa; Akira Kuriyama; Seigo Urushidani; Tetsunori Ikegami
Journal:  Acute Med Surg       Date:  2021-07-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.